Testing APBD drug candidates for restoration of multiple cell features and geneexpression profile
Awardee: Or Kakhlon
Institution: Hadassah Medical Organization
Award Amount: $52,978
Funding Period: January 1, 2018 - December 31, 2018
Previous
Previous
The impact of estrogen-promoted extracellular matrix-degrading programs on LAM progression
Next
Next